IDPH--Positive preliminary results for pivotal trial of ID Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: jay a who wrote (781)	4/30/1997 11:40:00 PM
From: I. Luttichuys	of 1762

Jay... (OT) This is the brief skinny on Oxandrin's indication and opinion on Oxandrin in the hospitals... Weight loss is a problem for many chronically ill patients (AIDS, CA, etc.). Up until now, drugs used to add weight have added fat and water weight which are a poor substitute for the protein mass reduction experienced by these patients. Oxandrin adds protein mass and thus is much preferred by the MDs. As weight loss is such a common problem, this drug should have very wide indications potentially. Could be a homerun. Right now it seems much talked about. I am hearing this from both MDs and students on their rotations at St. Vincent's Hospital in NYC. Looking forward to your analysis. BENNETT

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next